Global Bacillus Coagulans Supply, Demand and Key Producers, 2026-2032
Description
The global Bacillus Coagulans market size is expected to reach $ 365 million by 2032, rising at a market growth of 8.9% CAGR during the forecast period (2026-2032).
Bacillus Coagulans is a lactic acid-forming bacterial species within the genus Bacillus. The organism was first isolated and described as Bacillus Coagulans in 1915 by B.W. Hammer at the Iowa Agricultural Experiment Station as a cause of an outbreak of coagulation in evaporated milk packed by an Iowa condensary.
Market Driver:
The Bacillus Coagulans market is driven by the growing consumer demand for probiotics and functional foods that support digestive health and immunity. Bacillus coagulans, a spore-forming probiotic, is valued for its stability and ability to survive harsh manufacturing and gastrointestinal conditions, making it ideal for food, beverages, and dietary supplements. The increasing prevalence of gastrointestinal disorders and heightened awareness of gut health's role in overall wellness further boost market demand.
Market Challenge:
A major challenge in the Bacillus Coagulans market is the stringent regulatory environment for probiotics, requiring extensive research and compliance with safety and efficacy standards. The high cost of production and limited scalability due to specialized fermentation processes can restrict market expansion. Moreover, competition from other probiotics like Lactobacillus and Bifidobacterium strains adds pressure on manufacturers to differentiate their products.
Industry Trends:
The Bacillus Coagulans industry is witnessing innovation in product formulations, including heat-stable and multi-strain probiotic blends, to enhance versatility and effectiveness. The use of Bacillus coagulans in non-traditional applications, such as cosmetics and animal nutrition, is expanding its market potential. Additionally, advancements in fermentation technologies and collaborations between research institutions and companies are driving cost efficiencies and product quality improvements.
Global key players of Bacillus Coagulans include Kerry, WECARE-PROBIOTICS, Sabinsa, etc. The top three players hold a share about 82%. North America is the largest producer, has a share about 51%, followed by Japan and China, with share 17% and 14%, respectively. The largest market is North America, with a share about 31%, followed by Europe and China, both have a share about 24 percent.
This report studies the global Bacillus Coagulans production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Bacillus Coagulans and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Bacillus Coagulans that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Bacillus Coagulans total production and demand, 2021-2032, (MT)
Global Bacillus Coagulans total production value, 2021-2032, (USD Million)
Global Bacillus Coagulans production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (MT), (based on production site)
Global Bacillus Coagulans consumption by region & country, CAGR, 2021-2032 & (MT)
U.S. VS China: Bacillus Coagulans domestic production, consumption, key domestic manufacturers and share
Global Bacillus Coagulans production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (MT)
Global Bacillus Coagulans production by Cellular Activity, production, value, CAGR, 2021-2032, (USD Million) & (MT)
Global Bacillus Coagulans production by Application, production, value, CAGR, 2021-2032, (USD Million) & (MT)
This report profiles key players in the global Bacillus Coagulans market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Kerry, Sabinsa, Mitsubishi, Chr. Hansen, Synbiotech Inc., WECARE-PROBIOTICS, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Bacillus Coagulans market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (MT) and average price (USD/Kg) by manufacturer, by Cellular Activity, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Bacillus Coagulans Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Bacillus Coagulans Market, Segmentation by Cellular Activity:
Below 20 Billion CFU/g
20-100 Billion CFU/g
Above 100 Billion CFU/g
Global Bacillus Coagulans Market, Segmentation by Application:
Food and Beverage
Drugs
Supplement Products
Others
Companies Profiled:
Kerry
Sabinsa
Mitsubishi
Chr. Hansen
Synbiotech Inc.
WECARE-PROBIOTICS
Key Questions Answered:
1. How big is the global Bacillus Coagulans market?
2. What is the demand of the global Bacillus Coagulans market?
3. What is the year over year growth of the global Bacillus Coagulans market?
4. What is the production and production value of the global Bacillus Coagulans market?
5. Who are the key producers in the global Bacillus Coagulans market?
6. What are the growth factors driving the market demand?
Bacillus Coagulans is a lactic acid-forming bacterial species within the genus Bacillus. The organism was first isolated and described as Bacillus Coagulans in 1915 by B.W. Hammer at the Iowa Agricultural Experiment Station as a cause of an outbreak of coagulation in evaporated milk packed by an Iowa condensary.
Market Driver:
The Bacillus Coagulans market is driven by the growing consumer demand for probiotics and functional foods that support digestive health and immunity. Bacillus coagulans, a spore-forming probiotic, is valued for its stability and ability to survive harsh manufacturing and gastrointestinal conditions, making it ideal for food, beverages, and dietary supplements. The increasing prevalence of gastrointestinal disorders and heightened awareness of gut health's role in overall wellness further boost market demand.
Market Challenge:
A major challenge in the Bacillus Coagulans market is the stringent regulatory environment for probiotics, requiring extensive research and compliance with safety and efficacy standards. The high cost of production and limited scalability due to specialized fermentation processes can restrict market expansion. Moreover, competition from other probiotics like Lactobacillus and Bifidobacterium strains adds pressure on manufacturers to differentiate their products.
Industry Trends:
The Bacillus Coagulans industry is witnessing innovation in product formulations, including heat-stable and multi-strain probiotic blends, to enhance versatility and effectiveness. The use of Bacillus coagulans in non-traditional applications, such as cosmetics and animal nutrition, is expanding its market potential. Additionally, advancements in fermentation technologies and collaborations between research institutions and companies are driving cost efficiencies and product quality improvements.
Global key players of Bacillus Coagulans include Kerry, WECARE-PROBIOTICS, Sabinsa, etc. The top three players hold a share about 82%. North America is the largest producer, has a share about 51%, followed by Japan and China, with share 17% and 14%, respectively. The largest market is North America, with a share about 31%, followed by Europe and China, both have a share about 24 percent.
This report studies the global Bacillus Coagulans production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Bacillus Coagulans and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Bacillus Coagulans that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Bacillus Coagulans total production and demand, 2021-2032, (MT)
Global Bacillus Coagulans total production value, 2021-2032, (USD Million)
Global Bacillus Coagulans production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (MT), (based on production site)
Global Bacillus Coagulans consumption by region & country, CAGR, 2021-2032 & (MT)
U.S. VS China: Bacillus Coagulans domestic production, consumption, key domestic manufacturers and share
Global Bacillus Coagulans production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (MT)
Global Bacillus Coagulans production by Cellular Activity, production, value, CAGR, 2021-2032, (USD Million) & (MT)
Global Bacillus Coagulans production by Application, production, value, CAGR, 2021-2032, (USD Million) & (MT)
This report profiles key players in the global Bacillus Coagulans market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Kerry, Sabinsa, Mitsubishi, Chr. Hansen, Synbiotech Inc., WECARE-PROBIOTICS, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Bacillus Coagulans market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (MT) and average price (USD/Kg) by manufacturer, by Cellular Activity, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Bacillus Coagulans Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Bacillus Coagulans Market, Segmentation by Cellular Activity:
Below 20 Billion CFU/g
20-100 Billion CFU/g
Above 100 Billion CFU/g
Global Bacillus Coagulans Market, Segmentation by Application:
Food and Beverage
Drugs
Supplement Products
Others
Companies Profiled:
Kerry
Sabinsa
Mitsubishi
Chr. Hansen
Synbiotech Inc.
WECARE-PROBIOTICS
Key Questions Answered:
1. How big is the global Bacillus Coagulans market?
2. What is the demand of the global Bacillus Coagulans market?
3. What is the year over year growth of the global Bacillus Coagulans market?
4. What is the production and production value of the global Bacillus Coagulans market?
5. Who are the key producers in the global Bacillus Coagulans market?
6. What are the growth factors driving the market demand?
Table of Contents
103 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Manufacturers Competitive Analysis
- 4 United States VS China VS Rest of the World
- 5 Market Analysis by Cellular Activity
- 6 Market Analysis by Application
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
